GL1X · GenesisL1 explorer

Research workbench

Crystal structure of RV2671 from mycobacteirum tuberculosis in complex with dihydropteridine ring of dihydropteroic acid

Analyse Crystal structure of RV2671 from mycobacteirum tuberculosis in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4XT4
Type
protein
Length
246 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
RV2671
UniProt
P71968
Ligands
NAP, 44W
Pockets
3 · best druggability 0.59

Structure

x-ray diffraction · 1 distinct chain · 28% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARV2671protein24628% helix, 23% strandP71968

Ligands and binding sites

  • NAP · Nadp nicotinamide-adenine-dinucleotide phosphate · ligand · chains A
  • 44W · 2-amino-6-methyl-7,8-dihydropteridin-4(3H)-one · ligand · chains A
  • GOL · Glycerol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13070.590.7844NAP, 44W, GOL
22080.500.7631empty
31370.430.7520empty

Compared structures

  • 4XT4 · Crystal structure of Rv2671 from Mycobacteirum tuberculosis in complex with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.